| Code | Description | Claims | Beneficiaries | Total Paid |
| 80053 |
Comprehensive metabolic panel |
21,220 |
18,490 |
$1.29M |
| 36415 |
Collection of venous blood by venipuncture |
19,488 |
16,540 |
$1.19M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
25,536 |
24,274 |
$897K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,731 |
6,578 |
$683K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
11,212 |
9,652 |
$595K |
| 81025 |
|
10,574 |
9,959 |
$429K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
5,488 |
5,299 |
$401K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,662 |
3,496 |
$330K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,613 |
3,587 |
$325K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,895 |
5,098 |
$315K |
| 87081 |
|
3,165 |
3,097 |
$312K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,990 |
8,161 |
$309K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,953 |
8,919 |
$241K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,553 |
1,522 |
$195K |
| 81001 |
|
14,572 |
13,524 |
$188K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,072 |
14,222 |
$181K |
| 76830 |
Ultrasound, transvaginal |
1,734 |
1,633 |
$149K |
| 86850 |
|
1,845 |
1,728 |
$139K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,782 |
2,698 |
$132K |
| 86900 |
|
2,474 |
2,295 |
$129K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,075 |
2,863 |
$109K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
585 |
568 |
$108K |
| 82565 |
|
496 |
423 |
$107K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,477 |
4,251 |
$101K |
| 71046 |
Radiologic examination, chest; 2 views |
6,231 |
5,975 |
$97K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,580 |
3,387 |
$88K |
| 73610 |
|
1,563 |
1,502 |
$87K |
| 73630 |
|
1,747 |
1,683 |
$83K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
16,271 |
14,890 |
$82K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,691 |
5,392 |
$81K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
95 |
94 |
$77K |
| 81003 |
|
4,228 |
4,014 |
$70K |
| 73130 |
|
869 |
831 |
$69K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,337 |
2,244 |
$67K |
| 74018 |
|
1,537 |
1,456 |
$59K |
| 87077 |
|
2,417 |
2,320 |
$57K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,908 |
1,818 |
$55K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,417 |
1,367 |
$51K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
801 |
760 |
$50K |
| 84702 |
|
2,584 |
2,259 |
$50K |
| 73110 |
|
673 |
650 |
$46K |
| 71045 |
Radiologic examination, chest; single view |
7,171 |
6,574 |
$46K |
| 73564 |
|
1,504 |
1,406 |
$43K |
| 87210 |
|
1,398 |
1,324 |
$41K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
700 |
637 |
$39K |
| 93971 |
|
216 |
211 |
$35K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,575 |
2,350 |
$35K |
| 73030 |
|
759 |
731 |
$33K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,078 |
1,060 |
$32K |
| 71250 |
|
137 |
137 |
$31K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,849 |
1,742 |
$31K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,502 |
10,596 |
$30K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
32,502 |
27,714 |
$30K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,068 |
1,984 |
$24K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
735 |
728 |
$24K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
568 |
543 |
$23K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,403 |
1,302 |
$21K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
7,636 |
6,626 |
$20K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,040 |
982 |
$19K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,702 |
973 |
$19K |
| G0378 |
Hospital observation service, per hour |
2,901 |
2,396 |
$18K |
| 72110 |
|
568 |
555 |
$17K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,552 |
6,161 |
$16K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
179 |
173 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,299 |
2,247 |
$14K |
| 96376 |
|
2,930 |
1,997 |
$13K |
| 76770 |
|
197 |
194 |
$12K |
| 84484 |
|
7,126 |
5,933 |
$10K |
| 70496 |
|
75 |
73 |
$10K |
| 93017 |
|
222 |
215 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,536 |
2,186 |
$9K |
| 73140 |
|
69 |
69 |
$7K |
| 80076 |
|
1,986 |
1,830 |
$7K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
90 |
86 |
$7K |
| 12001 |
|
88 |
87 |
$7K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
763 |
724 |
$7K |
| 85027 |
|
3,034 |
2,679 |
$7K |
| 76775 |
|
193 |
187 |
$6K |
| 86140 |
|
2,735 |
2,397 |
$6K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
194 |
138 |
$6K |
| 73080 |
|
89 |
87 |
$5K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
12 |
12 |
$5K |
| J3490 |
Unclassified drugs |
5,593 |
3,105 |
$4K |
| 73090 |
|
53 |
51 |
$4K |
| 87070 |
|
13 |
12 |
$4K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
166 |
149 |
$4K |
| 87807 |
|
288 |
282 |
$4K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
29 |
27 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,101 |
7,855 |
$4K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,569 |
1,128 |
$3K |
| 82247 |
|
670 |
416 |
$3K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
13 |
13 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,971 |
2,817 |
$3K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,618 |
670 |
$3K |
| 76536 |
|
39 |
39 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,467 |
6,980 |
$3K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,282 |
1,242 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,619 |
7,105 |
$2K |
| 73590 |
|
30 |
29 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
117 |
110 |
$2K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,031 |
506 |
$2K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
212 |
207 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,583 |
3,414 |
$2K |
| 85379 |
|
2,014 |
1,931 |
$2K |
| 93976 |
|
1,191 |
1,138 |
$2K |
| 84145 |
|
911 |
792 |
$1K |
| 86308 |
|
29 |
29 |
$1K |
| 12011 |
|
14 |
14 |
$1K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
234 |
229 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,744 |
2,229 |
$1K |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
75 |
72 |
$1K |
| 97597 |
|
19 |
12 |
$1K |
| 80061 |
Lipid panel |
3,037 |
2,976 |
$993.96 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,597 |
3,537 |
$829.79 |
| 85007 |
|
1,404 |
1,243 |
$789.09 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
21 |
16 |
$782.71 |
| 87400 |
|
21 |
21 |
$771.37 |
| 83690 |
|
7,702 |
6,996 |
$745.03 |
| 72040 |
|
28 |
27 |
$744.69 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,198 |
3,954 |
$714.70 |
| 82803 |
|
649 |
595 |
$696.74 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
618 |
567 |
$690.31 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
161 |
156 |
$681.08 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
937 |
850 |
$678.75 |
| 74022 |
|
65 |
64 |
$629.33 |
| 83735 |
|
4,973 |
3,721 |
$505.29 |
| 83605 |
|
2,822 |
2,449 |
$446.75 |
| 82077 |
|
826 |
773 |
$422.30 |
| 87040 |
|
1,505 |
1,333 |
$413.02 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,601 |
2,208 |
$398.79 |
| 93308 |
|
94 |
90 |
$392.28 |
| 84439 |
|
578 |
545 |
$386.39 |
| 80143 |
|
117 |
112 |
$378.44 |
| 85610 |
|
3,095 |
2,757 |
$365.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,626 |
5,994 |
$363.13 |
| 82728 |
|
557 |
532 |
$358.60 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
774 |
743 |
$356.51 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
3,959 |
3,100 |
$337.56 |
| 83880 |
|
2,325 |
2,125 |
$271.58 |
| 83655 |
|
614 |
600 |
$209.42 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
45 |
13 |
$197.05 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,141 |
2,054 |
$167.08 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,024 |
1,939 |
$158.70 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
58 |
53 |
$121.87 |
| 85730 |
|
1,623 |
1,502 |
$42.50 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,917 |
1,702 |
$40.72 |
| 86901 |
|
2,474 |
2,295 |
$39.58 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
441 |
429 |
$31.58 |
| 87186 |
|
1,800 |
1,722 |
$26.67 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
852 |
711 |
$21.63 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,449 |
2,545 |
$14.87 |
| 84466 |
|
309 |
295 |
$11.64 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,856 |
1,487 |
$8.12 |
| 84100 |
|
1,530 |
1,070 |
$6.33 |
| 83540 |
|
416 |
398 |
$5.90 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
376 |
353 |
$1.95 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,108 |
1,982 |
$1.76 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
72 |
66 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
649 |
631 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
877 |
765 |
$0.00 |
| 82248 |
|
51 |
39 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
134 |
127 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
20 |
12 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
12 |
12 |
$0.00 |
| 80179 |
|
65 |
63 |
$0.00 |
| 90715 |
|
166 |
163 |
$0.00 |
| 84460 |
|
26 |
25 |
$0.00 |
| 59025 |
Fetal non-stress test |
15 |
13 |
$0.00 |
| 85014 |
|
31 |
28 |
$0.00 |
| 96367 |
|
67 |
53 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
45 |
41 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
117 |
110 |
$0.00 |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
14 |
14 |
$0.00 |
| 88312 |
|
12 |
12 |
$0.00 |
| 84450 |
|
25 |
24 |
$0.00 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
96 |
53 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
28 |
27 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
69 |
52 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
15 |
15 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
16 |
15 |
$0.00 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
18 |
18 |
$0.00 |
| 82550 |
|
240 |
212 |
$0.00 |
| 85651 |
|
788 |
696 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
836 |
681 |
$0.00 |
| 97162 |
|
180 |
172 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
898 |
421 |
$0.00 |
| 88304 |
|
79 |
78 |
$0.00 |
| 85652 |
|
864 |
820 |
$0.00 |
| 87486 |
|
29 |
28 |
$0.00 |
| 70498 |
|
79 |
77 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
816 |
735 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
133 |
109 |
$0.00 |
| 82607 |
|
115 |
110 |
$0.00 |
| 85018 |
|
62 |
55 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
14 |
12 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
13 |
12 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
12 |
12 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
90 |
79 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
29 |
27 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
23 |
13 |
$0.00 |
| 87581 |
|
29 |
28 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
27 |
13 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
12 |
12 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
14 |
13 |
$0.00 |
| 87205 |
|
13 |
12 |
$0.00 |